Methicillin-resistant Staphylococcus aureus: an evolving pathogen (Q38171759)

30 August 2017

Methicillin-resistant Staphylococcus aureus: an evolving pathogen (English)

1 reference

methicillin-resistant Staphylococcus aureus

30 August 2017

0 references

Staphylococcus aureus

object named as

Staphylococcus aureus

1 reference

2

G Ralph Corey

1 reference

30 August 2017

1

Martin E Stryjewski

1 reference

PubMed ID

24343827

30 August 2017

language of work or name

English

0 references

publication date

1 January 2014

1 reference

Clinical Infectious Diseases

30 August 2017

1 reference

30 August 2017

58 Suppl 1

1 reference

30 August 2017

S10-9

1 reference

The early recognition of streptococci as causes of disease

30 August 2017

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT613

Changing staphylococci and staphylococcal infections. A ten-year study of bacteria and cases of bacteremia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT613

Altered penicillin-binding proteins in methicillin-resistant strains of Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT613

A new class of genetic element, staphylococcus cassette chromosome mec, encodes methicillin resistance in Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT613

Classification of staphylococcal cassette chromosome mec (SCCmec): guidelines for reporting novel SCCmec elements

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT613

Tracking the evolutionary origin of the methicillin resistance gene: cloning and sequencing of a homologue of mecA from a methicillin susceptible strain of Staphylococcus sciuri.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT613

The evolutionary history of methicillin-resistant Staphylococcus aureus (MRSA)

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT613

Potential associations between hematogenous complications and bacterial genotype in Staphylococcus aureus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT613

Potential associations between severity of infection and the presence of virulence-associated genes in clinical strains of Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT613

Virulent combinations of adhesin and toxin genes in natural populations of Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT613

Emergence and resurgence of meticillin-resistant Staphylococcus aureus as a public-health threat

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT613

Methicillin-resistant staphylococci 1965-75

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT613

Frequency and some properties of clinical isolates of methicillin-resistant Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT613

Methicillin-resistant Staphylococcus aureus in Dublin 1971-84.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT613

Re-emergence of methicillin-resistant Staphylococcus aureus causing severe infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT613

Methicillin-resistant Staphylococcus aureus: implications for the 1990s and effective control measures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT613

Surveillance of methicillin-resistant Staphylococcus aureus in England and Wales, 1986–1990

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT613

Influence of LY146032 on human polymorphonuclear leucocytes in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT613

National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT613

Epidemiology of methicillin-resistant Staphylococcus aureus (MRSA) in Latin America

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT613

High prevalence of oxacillin-resistant Staphylococcus aureus isolates from hospitalized patients in Asia-Pacific and South Africa: results from SENTRY antimicrobial surveillance program, 1998-1999.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT613

Antibiotic resistant Staphylococcus aureus: a paradigm of adaptive power

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT613

Secrets of success of a human pathogen: molecular evolution of pandemic clones of meticillin-resistant Staphylococcus aureus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT613

Geographic distribution of Staphylococcus aureus causing invasive infections in Europe: a molecular-epidemiological analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT613

Methicillin-resistant Staphylococcus aureus central line-associated bloodstream infections in US intensive care units, 1997-2007.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT613

Epidemiology of Staphylococcus aureus blood and skin and soft tissue infections in the US military health system, 2005-2010.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT613

The rationale for revising the Clinical and Laboratory Standards Institute vancomycin minimal inhibitory concentration interpretive criteria for Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT613

Increased vancomycin MICs for Staphylococcus aureus clinical isolates from a university hospital during a 5-year period

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT613

Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT613

Activated cell-wall synthesis is associated with vancomycin resistance in methicillin-resistant Staphylococcus aureus clinical strains Mu3 and Mu50.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT613

Increase in glutamine-non-amidated muropeptides in the peptidoglycan of vancomycin-resistant Staphylococcus aureus strain Mu50.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT613

Epidemiological and microbiological characterization of infections caused by Staphylococcus aureus with reduced susceptibility to vancomycin, United States, 1997-2001.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT613

Reversion of the glycopeptide resistance phenotype in Staphylococcus aureus clinical isolates

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT613

Control and outcome of a large outbreak of colonization and infection with glycopeptide-intermediate Staphylococcus aureus in an intensive care unit

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT613

In vitro susceptibilities and molecular analysis of vancomycin-intermediate and vancomycin-resistant Staphylococcus aureus isolates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT613

Genetic analysis of a high-level vancomycin-resistant isolate of Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT613

Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT613

Clinical features associated with bacteremia due to heterogeneous vancomycin-intermediate Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT613

The quest to identify heterogeneously resistant vancomycin-intermediate Staphylococcus aureus strains

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT613

Performance of various testing methodologies for detection of heteroresistant vancomycin-intermediate Staphylococcus aureus in bloodstream isolates

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT613

Detection of Staphylococcus aureus isolates with heterogeneous intermediate-level resistance to vancomycin in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT613

Characterization of vancomycin-heteroresistant Staphylococcus aureus from the metropolitan area of Detroit, Michigan, over a 22-year period (1986 to 2007).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT613

Heterogeneous vancomycin-intermediate susceptibility phenotype in bloodstream methicillin-resistant Staphylococcus aureus isolates from an international cohort of patients with infective endocarditis: prevalence, genotype, and clinical significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT613

Relationship of vancomycin minimum inhibitory concentration to mortality in patients with methicillin-resistant Staphylococcus aureus hospital-acquired, ventilator-associated, or health-care-associated pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT613

An outbreak of heterogeneous glycopeptide-intermediate Staphylococcus aureus related to a device source in an intensive care unit.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT613

Antimicrobial resistance: the example of Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT613

Mobile genetic elements of Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT613

The emerging problem of linezolid-resistant Staphylococcus

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT613

Analysis of cell membrane characteristics of in vitro-selected daptomycin-resistant strains of methicillin-resistant Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT613

VraSR two-component regulatory system contributes to mprF-mediated decreased susceptibility to daptomycin in in vivo-selected clinical strains of methicillin-resistant Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT613

Clinical outbreak of linezolid-resistant Staphylococcus aureus in an intensive care unit.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT613

Community-acquired methicillin-resistant Staphylococcus aureus endocarditis in the Detroit Medical Center

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT613

Community-acquired methicillin-resistant Staphylococcus aureus infections in France: emergence of a single clone that produces Panton-Valentine leukocidin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT613

Community-acquired methicillin-resistant Staphylococcus aureus, Uruguay

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT613

Epidemiological typing of community-acquired methicillin-resistant Staphylococcus aureus isolates from children in Taiwan

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT613

Skin and soft-tissue infections caused by community-acquired methicillin-resistant Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT613

Association between Staphylococcus aureus strains carrying gene for Panton-Valentine leukocidin and highly lethal necrotising pneumonia in young immunocompetent patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT613

Emergence of community-acquired methicillin-resistant Staphylococcus aureus USA 300 clone as the predominant cause of skin and soft-tissue infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT613

Methicillin-ResistantS. aureusInfections among Patients in the Emergency Department

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT613

Panton-valentine leukocidin-positive and toxic shock syndrome toxin 1-positive methicillin-resistant Staphylococcus aureus: a French multicenter prospective study in 2008.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT613

Emergence of community-associated methicillin-resistant Staphylococcus aureus USA300 genotype as a major cause of health care-associated blood stream infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT613

Characteristics of patients with healthcare-associated infection due to SCCmec type IV methicillin-resistant Staphylococcus aureus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT613

Emergence of multidrug-resistant, community-associated, methicillin-resistant Staphylococcus aureus clone USA300 in men who have sex with men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT613

Occurrence of a USA300 vancomycin-intermediate Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT613

Daptomycin non-susceptible meticillin-resistant Staphylococcus aureus USA 300 isolate

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT613

Antimicrobial resistance: Not community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA)! A clinician's guide to community MRSA - its evolving antimicrobial resistance and implications for therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT613

Community-associated meticillin-resistant Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT613

Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT613

Is methicillin resistance associated with a worse prognosis in Staphylococcus aureus ventilator-associated pneumonia?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT613

Impact of methicillin resistance on outcome of Staphylococcus aureus ventilator-associated pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT613

Influence of vancomycin minimum inhibitory concentration on the treatment of methicillin-resistant Staphylococcus aureus bacteremia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT613

High-dose vancomycin therapy for methicillin-resistant Staphylococcus aureus infections: efficacy and toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT613

The clinical significance of vancomycin minimum inhibitory concentration in Staphylococcus aureus infections: a systematic review and meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT613

Systematic review and meta-analysis of the significance of heterogeneous vancomycin-intermediate Staphylococcus aureus isolates

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT613

Vancomycin heteroresistance is associated with reduced mortality in ST239 methicillin-resistant Staphylococcus aureus blood stream infections.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT613

Transcription profiling-based identification of Staphylococcus aureus genes regulated by the agr and/or sarA loci.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT613

Factors influencing time to vancomycin-induced clearance of nonendocarditis methicillin-resistant Staphylococcus aureus bacteremia: role of platelet microbicidal protein killing and agr genotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT613

Persistent bacteremia due to methicillin-resistant Staphylococcus aureus infection is associated with agr dysfunction and low-level in vitro resistance to thrombin-induced platelet microbicidal protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT613

Vancomycin in vitro bactericidal activity and its relationship to efficacy in clearance of methicillin-resistant Staphylococcus aureus bacteremia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT613

Increased mortality with accessory gene regulator (agr) dysfunction in Staphylococcus aureus among bacteremic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT613

Panton-Valentine leukocidin does play a role in the early stage of Staphylococcus aureus skin infections: a rabbit model

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT613

Involvement of Panton-Valentine leukocidin-producing Staphylococcus aureus in primary skin infections and pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT613

Presence of genes encoding the panton-valentine leukocidin exotoxin is not the primary determinant of outcome in patients with complicated skin and skin structure infections due to methicillin-resistant Staphylococcus aureus: results of a multinatio

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT613

Associations between the genotypes of Staphylococcus aureus bloodstream isolates and clinical characteristics and outcomes of bacteremic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT613

Presence of genes encoding panton-valentine leukocidin is not the primary determinant of outcome in patients with hospital-acquired pneumonia due to Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT613

Clinical impact of antimicrobial resistance in European hospitals: excess mortality and length of hospital stay related to methicillin-resistant Staphylococcus aureus bloodstream infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT613

Methicillin-resistant-Staphylococcus aureus hospitalizations, United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT613

Invasive methicillin-resistant Staphylococcus aureus infections in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT613

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT613

Antibiotic Choice May Not Explain Poorer Outcomes in Patients With Staphylococcus aureus Bacteremia and High Vancomycin Minimum Inhibitory Concentrations

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT613

21 January 2018

Identifiers

DOI

10.1093/CID/CIT613

1 reference

30 August 2017

1 reference

PubMed ID

24343827